The Oncosearch | Oncotarget

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

Miao Wang, Alex Yuang-chi Chang

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16533-16546

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

Francesca Toffalorio, Mariacarmela Santarpia, Davide Radice, Christopher Adrian Jaramillo, Gianluca Spitaleri, Michela Manzotti, Chiara Catania, Lars Petter Jordheim, Giuseppe Pelosi, Godefridus J. Peters, Carmelo Tibaldi, Niccola Funel, Lorenzo Spaggiari, Filippo de Braud, Tommaso De Pas, Elisa Giovannetti

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16437-16450

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer Research Paper

Florian Huemer, Gabriel Rinnerthaler, Theresa Westphal, Hubert Hackl, Georg Hutarew, Simon Peter Gampenrieder, Lukas Weiss, Richard Greil

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16512-16520

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience Research Paper

Elisa De Carlo, Maria Chiara Del Savio, Jerry Polesel, Valentina Da Ros, Eleonora Berto, Sandra Santarossa, Emanuela Chimienti, Lucia Fratino, Alessandra Bearz

Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15340-15349

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

Carina Heydt, Sebastian Michels, Kenneth S. Thress, Sven Bergner, JÃ¼rgen Wolf, Reinhard Buettner

Published Mar 16, 2018 · Vol. 9, No. 20 · pp. 15418-15434

PGE₂ mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells Research Paper

Lorenzo Bazzani, Sandra Donnini, Antonio Giachetti, Gerhard Christofori, Marina Ziche

Published Mar 13, 2018 · Vol. 9, No. 19 · pp. 14939-14958

Clinicopathological and prognostic significance of Twist overexpression in NSCLC Meta-Analysis

Meng Li, Xing Zhang, Xiaoqing Xu, Jiubin Wu, Kaiwen Hu, Xiuwei Guo, Peitong Zhang

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14642-14651

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog Research Paper

Bhairavi Tolani, Ngoc T. Hoang, Luis A. Acevedo, Etienne Giroux Leprieur, Hui Li, Biao He, David M. Jablons

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14311-14323

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis Meta-Analysis

Shiqian Han, Yuanduo Hong, Tingting Liu, Na Wu, Zhijia Ye

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14619-14629

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

Daniel Richard Gomez, Lauren Averett Byers, Monique Nilsson, Lixia Diao, Jing Wang, Lerong Li, Pan Tong, Mia Hofstad, Babita Saigal, Ignacio Wistuba, Neda Kalhor, Stephen Swisher, Youhong Fan, Waun Ki Hong, Milind Suraokar, Carmen Behrens, Cesar Moran, John Victor Heymach

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14268-14284

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2 Research Paper

Ming-Jenn Chen, De-Wei Wu, Gao-Chang Wang, Yao-Chen Wang, Chi-Yi Chen, Huei Lee

Published Feb 9, 2018 · Vol. 9, No. 17 · pp. 13758-13767

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer Research Paper

Maher Albitar, Sucha Sudarsanam, Wanlong Ma, Shiping Jiang, Wayne Chen, Vincent Funari, Forrest Blocker, Sally Agersborg

Published Feb 8, 2018 · Vol. 9, No. 17 · pp. 13682-13693

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer Research Paper

Lianghua Fang, Hui Chen, Zhenya Tang, Neda Kalhor, Ching-Hua Liu, Hui Yao, Shimin Hu, Pei Lin, Jin Zhao, Raja Luthra, Rajesh R. Singh, Mark J. Routbort, David Hong, L. Jeffrey Medeiros, Xinyan Lu

Published Feb 7, 2018 · Vol. 9, No. 16 · pp. 12959-12970

An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas Research Paper

Jarrod D. Predina, Andrew D. Newton, Leilei Xia, Christopher Corbett, Courtney Connolly, Michael Shin, Lydia Frezel Sulyok, Leslie Litzky, Charuhas Deshpande, Shuming Nie, Sumith A. Kularatne, Phillip S. Low, Sunil Singhal

Published Feb 5, 2018 · Vol. 9, No. 17 · pp. 13517-13529

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments Research Paper

Costi Alifrangis, Philip Carter, Biancastella Cereser, Pramodh Chandrasinghe, Lisa Del Bel Belluz, Eric Lim, Nina Moderau, Fotini Poyia, Neha Tabassum, Hua Zhang, Jonathan Krell, Justin Stebbing

Published Feb 1, 2018 · Vol. 9, No. 16 · pp. 12805-12811

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer Priority Research Paper

Amanda B. Pilling, Jihye Kim, Adriana Estrada-Bernal, Qiong Zhou, Anh T. Le, Katherine R. Singleton, Lynn E. Heasley, Aik Choon Tan, James DeGregori, Robert C. Doebele

Published Jan 16, 2018 · Vol. 9, No. 10 · pp. 8823-8835

Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer Research Paper

Aleksi Suo, Allison Childers, Adrijana Dâ€™Silva, Lars F. Petersen, Shannon Otsuka, Michelle Dean, Haocheng Li, Emeka K. Enwere, Brant Pohorelic, Alexander Klimowicz, Ivana A. Souza, Jawed Hamid, Gerald W. Zamponi, DGwyn Bebb

Published Jan 12, 2018 · Vol. 9, No. 9 · pp. 8573-8583

PLIN2 confers gefitinib resistance by inhibiting cell apoptosis via activation of EGFR/AKT/survivin in PC9R cells Research Paper

Meijia Chang, Jie Hu, Tao Fang, Jing Li, Yuanlin Song, Chunxue Bai, Jian Zhou

Published Jan 11, 2018 · Vol. 5

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells Research Paper

Mengfan Qi, Ye Tian, Wang Li, Dan Li, Tian Zhao, Yuxin Yang, Qiwen Li, Sujun Chen, Yan Yang, Zhixiong Zhang, Liang Tang, Zhonghua Liu, Bo Su, Fei Li, Yonghong Feng, Ke Fei, Peng Zhang, Fan Zhang, Lei Zhang

Published Jan 10, 2018 · Vol. 9, No. 15 · pp. 12020-12034

Structural insights into drug development strategy targeting EGFR T790M/C797S Research Paper

Su-Jie Zhu, Peng Zhao, Jiao Yang, Rui Ma, Xiao-E Yan, Sheng-Yong Yang, Jing-Wen Yang, Cai-Hong Yun

Published Jan 10, 2018 · Vol. 9, No. 17 · pp. 13652-13665

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer Research Paper

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience Research Paper

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

PGE₂ mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells Research Paper

Clinicopathological and prognostic significance of Twist overexpression in NSCLC Meta-Analysis

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog Research Paper

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis Meta-Analysis

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2 Research Paper

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer Research Paper

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer Research Paper

An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas Research Paper

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments Research Paper

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer Priority Research Paper

Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer Research Paper

PLIN2 confers gefitinib resistance by inhibiting cell apoptosis via activation of EGFR/AKT/survivin in PC9R cells Research Paper

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells Research Paper

Structural insights into drug development strategy targeting EGFR T790M/C797S Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Molecular mechanism of action and potential biomarkers of growth inhibition of synergistic combination of afatinib and dasatinib against gefitinib-resistant non-small cell lung cancer cells Research Paper

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer Research Paper

Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer Research Paper

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience Research Paper

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance Review

PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells Research Paper

Clinicopathological and prognostic significance of Twist overexpression in NSCLC Meta-Analysis

Preclinical characterization of therapeutic antibodies targeted at the carboxy-terminus of Sonic hedgehog Research Paper

The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis Meta-Analysis

Integrative proteomic and transcriptomic analysis provides evidence for TrkB (NTRK2) as a therapeutic target in combination with tyrosine kinase inhibitors for non-small cell lung cancer Research Paper

MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2 Research Paper

Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer Research Paper

MET amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancer Research Paper

An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas Research Paper

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments Research Paper

ALK is a critical regulator of the MYC-signaling axis in ALK positive lung cancer Priority Research Paper

Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer Research Paper

PLIN2 confers gefitinib resistance by inhibiting cell apoptosis via activation of EGFR/AKT/survivin in PC9R cells Research Paper

ERK inhibition represses gefitinib resistance in non-small cell lung cancer cells Research Paper

Structural insights into drug development strategy targeting EGFR T790M/C797S Research Paper

PGE₂ mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells Research Paper